{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Gilead Sciences", "item": "https://www.patentleaderboard.com/2021/company/gilead-sciences"}, {"@type": "ListItem", "position": 4, "name": "Stephane Perreault", "item": "https://www.patentleaderboard.com/2021/inventor/fl:st_ln:perreault-7"}]}

Home › 2021 › Gilead Sciences › Stephane Perreault

SP

Stephane Perreault — 3 Patents in 2021

GSGilead Sciences: 3 patents #25 of 206Top 15%

Brier, WA: #3 of 16 inventorsTop 20%

Washington: #1,376 of 13,672 inventorsTop 15%

Overall (2021): #62,093 of 548,734Top 15%

3 Patents 2021

Issued Patents 2021

Showing 1–3 of 3 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
11179383	Compounds for inhibition of α4β7 integrin	Peter A. Blomgren, Taryn Campbell, Jayaraman Chandrasekhar, Christopher T. Clark, Julian A. Codelli +12 more	2021-11-23	$216,502,000
11174256	Imidazopyridine derivatives	Peter A. Blomgren, Taryn Campbell, Jayaraman Chandrasekhar, Christopher T. Clark, Julian A. Codelli +12 more	2021-11-16	$422,244,000
11116760	Quinoline derivatives	Peter A. Blomgren, Taryn Campbell, Jayaraman Chandrasekhar, Christopher T. Clark, Julian A. Codelli +12 more	2021-09-14	$147,264,000

Stephane Perreault — 3 Patents in 2021

Issued Patents 2021

Patent Widget